Daniel Pharand
- Surgery top 2%
- Bladder and Urothelial Cancer Treatments 10
- Urinary and Genital Oncology Studies 5
- Adrenal and Paraganglionic Tumors 3
- Urology top 2%
-
- Renal cell carcinoma treatment 8
- Prostate Cancer Diagnosis and Treatment 5
- Cancer Research top 10%
-
- Renal and related cancers 7
-
- Multiple and Secondary Primary Cancers 2
-
- Cardiac, Anesthesia and Surgical Outcomes 2
In The Last Decade
Daniel Pharand
26 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 59
- Endocrinology, Diabetes and Metabolism 544
- Surgery 1.2k
- Urology 163
- Pulmonary and Respiratory Medicine 585
- Cancer Research 213
Countries citing papers authored by Daniel Pharand
This map shows the geographic impact of Daniel Pharand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Pharand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Pharand more than expected).
Fields of papers citing papers by Daniel Pharand
This network shows the impact of papers produced by Daniel Pharand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Pharand. The network helps show where Daniel Pharand may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Pharand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 3 | |
| 2 | 2011 | 25 | |
| 3 | 2011 | 1 | |
| 4 | 2009 | 18 | |
| 5 | 2009 | 118 | |
| 6 | 2009 | 55 | |
| 7 | 2009 | 74 | |
| 8 | 2009 | 29 | |
| 9 | 2008 | 9 | |
| 10 | 2008 | 30 | |
| 11 | 2008 | 22 | |
| 12 | 2008 | 37 | |
| 13 | 2008 | 12 | |
| 14 | 2008 | 37 | |
| 15 | 2008 | 33 | |
| 16 | Long term follow-up of intravesical Bacillus Calmette-Guerin for the treatment of bladder transitional cell carcinoma. | 2000 | 3 |
| 17 | 1997 | 465 | |
| 18 | 1996 | 162 | |
| 19 | 1993 | 83 | |
| 20 | 1993 | 52 |
About Daniel Pharand
Daniel Pharand is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Urology, Cancer Research and Geriatrics and Gerontology, having authored 26 papers that have together received 1.6k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Renal cell carcinoma treatment (8 papers), Renal and related cancers (7 papers), Prostate Cancer Diagnosis and Treatment (5 papers), Urinary and Genital Oncology Studies (5 papers), Adrenal and Paraganglionic Tumors (3 papers), Multiple and Secondary Primary Cancers (2 papers) and Cardiac, Anesthesia and Surgical Outcomes (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (544 citations), Surgery (1.2k citations), Urology (163 citations), Pulmonary and Respiratory Medicine (585 citations) and Cancer Research (213 citations). Daniel Pharand has collaborated with scholars based in Canada, Italy and Germany. Frequent co-authors include Alfons Pomp, Michel Gagner, André Lacroix, B. Todd Heniford, Claudio Jeldres, Paul Perrotte, Philippe Arjane, Francesco Montorsi, Shahrokh F. Shariat and Hugues Widmer. Their work appears in journals such as The Journal of Urology, British Journal of Urology, Urology, International Journal of Radiation Oncology*Biology*Physics and Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.